Actinium Pharmaceuticals
ATNM
27 hedge funds and large institutions have $4.33M invested in Actinium Pharmaceuticals in 2015 Q3 according to their latest regulatory filings, with 3 funds opening new positions, 10 increasing their positions, 8 reducing their positions, and 15 closing their positions.
25% more repeat investments, than reductions
Existing positions increased: 10 | Existing positions reduced: 8
0.02% less ownership
Funds ownership: 0.22% → 0.2% (-0.02%)
31% less funds holding
Funds holding: 39 → 27 (-12)
35% less capital invested
Capital invested by funds: $6.63M → $4.33M (-$2.3M)
75% less call options, than puts
Call options by funds: $35K | Put options by funds: $138K
80% less first-time investments, than exits
New positions opened: 3 | Existing positions closed: 15
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
BIT
BlackRock Institutional Trust
San Francisco,
California
|
+$683K |
| 2 |
Vanguard Group
Malvern,
Pennsylvania
|
+$257K |
| 3 |
SM
Sabby Management
Miami Beach,
Florida
|
+$152K |
| 4 |
BCM
Bridgeway Capital Management
Houston,
Texas
|
+$103K |
| 5 |
Deutsche Bank
Frankfurt Am Main Ge,
Germany
|
+$64.2K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Northern Trust
Chicago,
Illinois
|
-$427K |
| 2 |
TCIM
TIAA CREF Investment Management
New York
|
-$304K |
| 3 |
Squarepoint
New York
|
-$138K |
| 4 |
Jane Street
New York
|
-$129K |
| 5 |
COPPSERS
Commonwealth of Pennsylvania Public School Employees Retirement System
Harrisburg,
Pennsylvania
|
-$118K |
ATNM Hedge Fund Activity: Q3 2015 in Review
27 of the 3,582 institutional investors tracked by Wall St. Rank reported a position in Actinium Pharmaceuticals (ATNM) for Q3 2015, worth a combined $4.33M — down 35% from $6.63M a quarter earlier.
Sellers outnumbered buyers: 15 funds closed out of ATNM and 3 opened new positions — a net loss of 12 holders — while 8 trimmed existing stakes and 10 added.
The largest buyer was BlackRock Institutional Trust, opening a new position worth an estimated $683K. The largest seller was Northern Trust, cutting an estimated $427K.
- 27 institutional investors held Actinium Pharmaceuticals (ATNM) as of Q3 2015, down from 39 in Q2 2015.
- Funds reported $4.33M of Actinium Pharmaceuticals stock for Q3 2015, down 35% quarter-over-quarter.
- 3 funds opened new Actinium Pharmaceuticals positions in Q3 2015 and 15 closed out, a net change of -12 holders.
- The largest Actinium Pharmaceuticals buyer in Q3 2015 was BlackRock Institutional Trust, an estimated $683K added.
- The largest Actinium Pharmaceuticals seller in Q3 2015 was Northern Trust, an estimated $427K sold.
Based on aggregated 13F filings for Q3 2015.